Izencitinib
N/A
Report date: 2025/12/27 20:00:14
NME
Base Information
Drug NameIzencitinib
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[28]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheravance Biopharma Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesTheravance Biopharma IncJohnson & Johnson
Active IndicationsN/A
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A